Monte Rosa Therapeutics Inc

2
NAS:GLUE (USA)  
$ 5.76 +0.1 (+1.78%) 10:08 PM EST
At Loss
P/B:
1.56
Market Cap:
$ 288.47M
Enterprise V:
$ 156.39M
Volume:
46.31K
Avg Vol (2M):
154.64K
Volume:
46.31K
At Loss
Avg Vol (2M):
154.64K

Business Description

Monte Rosa Therapeutics Inc
NAICS : 541714 SIC : 2834
ISIN : US61225M1027
Description
Monte Rosa Therapeutics Inc is a biopharmaceutical company involved in developing a portfolio of novel small molecule precision medicines that employ the body's natural mechanisms to degrade therapeutically relevant proteins. It has developed a protein degradation platform, called QuEEN, that enables to rapidly identify protein targets and molecular glue degrader, or MGD, product candidates.
Name Current Vs Industry Vs History
Cash-To-Debt 3.85
Equity-to-Asset 0.73
Debt-to-Equity 0.25
Debt-to-EBITDA -0.34
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 1/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year EBITDA Growth Rate -49.5
3-Year EPS without NRI Growth Rate -49.2
3-Year FCF Growth Rate -48.7

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 64.74
9-Day RSI 59.19
14-Day RSI 55.95
6-1 Month Momentum % -12.21
12-1 Month Momentum % -12.48

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 8.09
Quick Ratio 8.09
Cash Ratio 7.89

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -64.2
Shareholder Yield % -4.45

Financials (Next Earnings Date:2024-05-10 Est.)

GLUE's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:GLUE

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Monte Rosa Therapeutics Inc Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $)
EPS (TTM) ($) -2.69
Beta 0
Volatility % 128.36
14-Day RSI 55.95
14-Day ATR ($) 0.47032
20-Day SMA ($) 5.18875
12-1 Month Momentum % -12.48
52-Week Range ($) 2.44 - 8.8334
Shares Outstanding (Mil) 50.08

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 1
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Monte Rosa Therapeutics Inc Filings

Filing Date Document Date Form
No Filing Data

Monte Rosa Therapeutics Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Monte Rosa Therapeutics Inc Frequently Asked Questions

What is Monte Rosa Therapeutics Inc(GLUE)'s stock price today?
The current price of GLUE is $5.76. The 52 week high of GLUE is $8.83 and 52 week low is $2.44.
When is next earnings date of Monte Rosa Therapeutics Inc(GLUE)?
The next earnings date of Monte Rosa Therapeutics Inc(GLUE) is 2024-05-10 Est..
Does Monte Rosa Therapeutics Inc(GLUE) pay dividends? If so, how much?
Monte Rosa Therapeutics Inc(GLUE) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1